Skip to main content
. 2018 Aug 8;9:876. doi: 10.3389/fphar.2018.00876

Table 3.

Recurrent VTE at different follow-up periods.

No. studies No. patients Recurrence rate (%) (sulodexide/control) RR (95% CI) P-value
6-month follow-up 4 1,461 2.40/4.79 0.47 [0.27, 0.83] 0.009
12-month follow-up 3 1,311 3.47/7.68 0.42 [0.26, 0.68] 0.0004
18-month follow-up 2 906 3.48/6.11 0.53 [0.29, 0.98] 0.04
24-month follow-up 3 1,311 4.89/9.45 0.49 [0.33, 0.74] 0.0007

RR, relative risk; CI, confidence intervals.